Circular RNA hsa_circ_0032463 Acts as the Tumor Promoter in Osteosarcoma by Regulating the MicroRNA 498/LEF1 Axis

REFERENCES

• Siegel RL, Miller KD, Jemal A. 2017. Cancer statistics, 2017. CA Cancer J Clin 67:7–30. https://doi.org/10.3322/caac.21387.
   PubMed Web of Science ®Google Scholar
• Aponte-Tinao L, Ayerza MA, Muscolo DL, Farfalli GL. 2015. Survival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the knee. Clin Orthop Relat Res 473:1789–1796. https://doi.org/10.1007/s11999-014-4028-5.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. 2018. CircRNA: a novel type of biomarker for cancer. Breast Cancer 25:1–7. https://doi.org/10.1007/s12282-017-0793-9.
   PubMed Web of Science ®Google Scholar
• Patop IL, Kadener S. 2018. circRNAs in cancer. Curr Opin Genet Dev 48:121–127. https://doi.org/10.1016/j.gde.2017.11.007.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu H, Hou L, Wang G, Zhang R, Huang Y, Chen X, Zhu J. 2017. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer 16:151. https://doi.org/10.1186/s12943-017-0719-3.
   PubMed Web of Science ®Google Scholar
• Lu Q, Liu T, Feng H, Yang R, Zhao X, Chen W, Jiang B, Qin H, Guo X, Liu M, Li L, Guo H. 2019. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer 18:111. https://doi.org/10.1186/s12943-019-1040-0.
   PubMed Web of Science ®Google Scholar
• Liu W, Ma W, Yuan Y, Zhang Y, Sun S. 2018. Circular RNA hsa_circRNA_103809 promotes lung cancer progression via facilitating ZNF121-dependent MYC expression by sequestering miR-4302. Biochem Biophys Res Commun 500:846–851. https://doi.org/10.1016/j.bbrc.2018.04.172.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xie Z, Chen J, Chen J, Ni W, Ma Y, Huang K, Wang G, Wang J, Ma J, Shen S, Fan S. 2019. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer 18:73. https://doi.org/10.1186/s12943-019-1007-1.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhou H, Yuan K, Xie R, Chen C. 2020. Overexpression of hsa_circ_0136666 predicts poor prognosis and initiates osteosarcoma tumorigenesis through miR-593-3p/ZEB2 pathway. Aging 12:10488–10496. https://doi.org/10.18632/aging.103273.
   PubMedGoogle Scholar
• Zhang PR, Ren J, Wan JS, Sun R, Li Y. 2020. Circular RNA hsa_circ_0002052 promotes osteosarcoma via modulating miR-382/STX6 axis. Hum Cell 33:810–818. https://doi.org/10.1007/s13577-020-00335-9.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. 2014. MicroRNAs in cancer. Annu Rev Pathol 9:287–314. https://doi.org/10.1146/annurev-pathol-012513-104715.
   PubMed Web of Science ®Google Scholar
• Zhou W, Wu Y, Pan M, Liu D, Liu B. 2019. Proliferation and migration of lung cancer could be inhibited by oxymatrine through the regulation for miR-520/VEGF. Am J Chin Med 47:865–878. https://doi.org/10.1142/S0192415X19500459.
   PubMed Web of Science ®Google Scholar
• Fang Y, Zhou W, Rong Y, Kuang T, Xu X, Wu W, Wang D, Lou W. 2019. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. Exp Cell Res 383:111543. https://doi.org/10.1016/j.yexcr.2019.111543.
   PubMed Web of Science ®Google Scholar
• Gao N, Wang FX, Wang G, Zhao QS. 2018. Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors. Eur Rev Med Pharmacol Sci 22:1693–1699. https://doi.org/10.26355/eurrev_201803_14582.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu X, Ge G, Zang X, Shao M, Zou S, Zhang Y, Mao Z, Zhang J, Mao F, Qian H, Xu W. 2019. miR-498 inhibits the growth and metastasis of liver cancer by targeting ZEB2. Oncol Rep 41:1638–1648. https://doi.org/10.3892/or.2018.6948.
   PubMed Web of Science ®Google Scholar
• Morgan RG, Ridsdale J, Payne M, Heesom KJ, Wilson MC, Davidson A, Greenhough A, Davies S, Williams AC, Blair A, Waterman ML, Tonks A, Darley RL. 2019. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells. Haematologica 104:1365–1377. https://doi.org/10.3324/haematol.2018.202846.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhang C. 2020. Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia. PLoS One 15:e0232520. https://doi.org/10.1371/journal.pone.0232520.
   Google Scholar
• DasGupta R, Fuchs E. 1999. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126:4557–4568. https://doi.org/10.1242/dev.126.20.4557.
   PubMed Web of Science ®Google Scholar
• Petersson M, Brylka H, Kraus A, John S, Rappl G, Schettina P, Niemann C. 2011. TCF/Lef1 activity controls establishment of diverse stem and progenitor cell compartments in mouse epidermis. EMBO j 30:3004–3018. https://doi.org/10.1038/emboj.2011.199.
   PubMed Web of Science ®Google Scholar
• Fang S, Liu M, Li L, Zhang FF, Li Y, Yan Q, Cui YZ, Zhu YH, Yuan YF, Guan XY. 2019. Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway. Oncogene 38:4061–4074. https://doi.org/10.1038/s41388-019-0704-y.
   PubMed Web of Science ®Google Scholar
• Wang A, Zhao C, Gao Y, Duan G, Yang Y, Fan B, Wang X, Wang K. 2019. LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/FOXP1 axis in lung cancer. Invest New Drugs 37:1127–1134. https://doi.org/10.1007/s10637-018-00721-z.
   PubMed Web of Science ®Google Scholar
• Yuan M, Zhang X, Zhang J, Wang K, Zhang Y, Shang W, Zhang Y, Cui J, Shi X, Na H, Fang D, Zuo Y, Ren S. 2020. DC-SIGN-LEF1/TCF1-miR-185 feedback loop promotes colorectal cancer invasion and metastasis. Cell Death Differ 27:379–395. https://doi.org/10.1038/s41418-019-0361-2.
   PubMed Web of Science ®Google Scholar
• Lu X, Qiao L, Liu Y. 2020. Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1. J Cell Biochem 121:4064–4073. https://doi.org/10.1002/jcb.29579.
   PubMed Web of Science ®Google Scholar
• Pongsuchart M, Kuchimaru T, Yonezawa S, Tran DTP, Kha NT, Hoang NTH, Kadonosono T, Kizaka-Kondoh S. 2018. Novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs. Cancer Sci 109:2746–2756. https://doi.org/10.1111/cas.13702.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu G, Wu Y, Ma J, Wu H, Xie Z, Chen S, Yang Y, Wang S, Shen P, Fang Y, Fan S, Shen S, Fang X. 2019. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling. Mol Cancer 18:150. https://doi.org/10.1186/s12943-019-1076-1.
   PubMed Web of Science ®Google Scholar
• Xiang D, Li Y, Lin Y. 2020. Circular RNA circCCDC66 contributes to malignant phenotype of osteosarcoma by sponging miR-338-3p to upregulate the expression of PTP1B. Biomed Res Int 2020:4637109. https://doi.org/10.1155/2020/4637109.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Sui Y, Luan L, Li B, Qin C. 2020. Retracted: a novel CircRNA Circ_0095424 regulates proliferation, metastasis, and apoptosis of osteosarcoma cells via the PI3K/AKT signaling pathway through targeting the miR-1238/HMGB1 axis. Cancer Biother Radiopharm https://doi.org/10.1089/cbr.2020.3563.
   Google Scholar
• Gu H, Cheng X, Xu J, Zhou K, Bian C, Chen G, Yin X. 2020. Circular RNA circFAT1(e2) promotes osteosarcoma progression and metastasis by sponging miR-181b and regulating HK2 expression. Biomed Res Int 2020:3589871. https://doi.org/10.1155/2020/3589871.
   PubMed Web of Science ®Google Scholar
• Dai F, Liu T, Zheng S, Liu Q, Yang C, Zhou J, Chen Y, Sheyhidin I, Lu X. 2016. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma. Tumour Biol 37:14595–14604. https://doi.org/10.1007/s13277-016-5338-x.
   PubMedGoogle Scholar
• Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. 2011. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17:211–215. https://doi.org/10.1038/nm.2284.
   PubMed Web of Science ®Google Scholar
• Hwang WL, Jiang JK, Yang SH, Huang TS, Lan HY, Teng HW, Yang CY, Tsai YP, Lin CH, Wang HW, Yang MH. 2014. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol 16:268–280. https://doi.org/10.1038/ncb2910.
   PubMed Web of Science ®Google Scholar
• Wang T, Hao Z, Liu C, Yuan L, Li L, Yin M, Li Q, Qi Z, Wang Z. 2020. LEF1 mediates osteoarthritis progression through circRNF121/miR-665/MYD88 axis via NF-кB signaling pathway. Cell Death Dis 11:598. https://doi.org/10.1038/s41419-020-02769-3.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao Y, Lu Q, Fei X, Lu C, Li C, Chen H. 2020. MiR-34a-5p inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in esophageal squamous cell carcinoma by targeting LEF1 and inactivation of the Hippo-YAP1/TAZ signaling pathway. J Cancer 11:3072–3081. https://doi.org/10.7150/jca.39861.
   PubMed Web of Science ®Google Scholar